Trials / Completed
CompletedNCT01104714
Pharmacogenetic Response to Chemotherapy Induction for ORL Cancers
Pharmacogenetic and Pharmacokinetic Aspects of the Response to Chemotherapy Induction Using Docetaxel, Cisplatin and 5-Fluorouracile (TPF)in ORL Cancers
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 90 (actual)
- Sponsor
- Centre Hospitalier Universitaire de Nīmes · Academic / Other
- Sex
- All
- Age
- 30 Years – 80 Years
- Healthy volunteers
- Not accepted
Summary
The purpose of this study is to determine if there is a correlation between tumor response after 3 doses of chemotherapy by induction using Docetaxel, Cisplatine and 5-Fluorouracile for advanced stage epidermoid carcinomas of the upper aero digestive tract and the presence of one or a combination of 3 genetic polymorphisms and/or 5 intra-tumoral transcriptional modifications.
Conditions
- Carcinoma, Squamous Cell
- Mouth Neoplasms
- Oropharyngeal Neoplasms
- Laryngeal Neoplasms
- Hypopharyngeal Neoplasms
Timeline
- Start date
- 2010-04-01
- Primary completion
- 2014-07-01
- Completion
- 2014-07-01
- First posted
- 2010-04-15
- Last updated
- 2015-03-26
Locations
14 sites across 1 country: France
Source: ClinicalTrials.gov record NCT01104714. Inclusion in this directory is not an endorsement.